GGrantIndex
Sort

50,496 grants matching lung cancer

ISG15 and Protein ISGylation in Cancer

$414,306
Dong-Er Zhang · University Of California, San Diego · R01 · FY2021 · CA

Project 2: The Impact of Immunotherapy on Human Vaccination

$414,295
E. John Wherry · Massachusetts General Hospital · U19 · FY2019 · AI

Epigenetic modulation of the TAZ-CAMTA1 transcriptional program by the Ada2a-containing histone acetyltransferase complex

$414,270
Munir Tanas · University Of Iowa · R01 · FY2021 · CA

Child Health ResearcH Career Development Award (CHRCDA) Program (K12)

$414,238
Gary Robert Fleisher · Boston Children'S Hospital · K12 · FY2020 · HD

Prostate Cancer Recovery Enhancement (PROCARE) for African American Men

$414,230
Lisa C Campbell · Duke University · R01 · FY2007 · CA

Clinical Trials Office

$414,213
Scott A Baker · University Of Minnesota · P30 · FY2010 · CA

Biomechanics of Blood Stream Infections

$414,193
John G Younger · University Of Michigan At Ann Arbor · R01 · FY2010 · GM

Neu5Gc and anti-Neu5Gc antibodies for detection of cancer and cancer risk

$414,190
Ajit P Varki · University Of California, San Diego · U01 · FY2008 · CA

A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children

$414,188
Yin Wang · University Of Maryland Baltimore · R01 · FY2021 · CA

Blocking tumor progression in therapy-responsive RET aberration-associated cancer

$414,123
Jie Wu · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · CA

The Role of the Nicotinic Cholinergic Pathway in Retinopathy of Prematurity

$414,079
John P Cooke · Stanford University · R01 · FY2011 · EY

Prostatitis and Prostate Cancer Development

$414,029
Lawrence Fong · University Of California, San Francisco · R01 · FY2015 · CA

Prostatitis and Prostate Cancer Development

$414,029
Lawrence Fong · University Of California, San Francisco · R01 · FY2016 · CA

Prostatitis and Prostate Cancer Development

$414,029
Lawrence Fong · University Of California, San Francisco · R01 · FY2012 · CA

Chemical Cell Surface Engineering

$414,006
Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2014 · GM

Lung epithelium collaborates with alveolar macrophages in host defense

$414,000
Min Wu · University Of North Dakota · R15 · FY2012 · AI

PDT of Head and Neck Cancer

$413,973
Nestor Rafael Rigual · Roswell Park Cancer Institute Corp · P01 · FY2012 · CA

IMPROVING THE DIAGNOSTIC SPECIFICITY OF CT FOR EARLY DETECTION OF LUNG CANCER: 4D CT-BASED PULMONARY NODULE ELASTOMETRY

$413,965
The Leland Stanford Junior University · · FY2012 · Department of Defense

Translational Apparatus as a Target for Drug Discovery

$413,945
University Of Minnesota Twin Cities · U01 · FY2003 · CA

Persistent transcriptional changes induced by nickel through epigenetic alterations

$413,876
Suresh Cuddapah · New York University School Of Medicine · R01 · FY2023 · ES

CT-Bronchoscopy Workstation for Lung-Cancer Assessment

$413,858
Endographics Imaging Systems, Inc. · R44 · FY2004 · CA

Triple Quadrupole (Q-Trap) Mass Spectrometer

$413,850
Thomas A Neubert · New York University School Of Medicine · S10 · FY2007 · RR

The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma

$413,844
Rani E George · Dana-Farber Cancer Inst · R01 · FY2018 · CA

The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma

$413,844
Rani E George · Dana-Farber Cancer Inst · R01 · FY2017 · CA

The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma

$413,844
Rani E George · Dana-Farber Cancer Inst · R01 · FY2020 · CA